A phase II and pharmacokinetic study of SB-715992, in patients with metastatic hepatocellular carcinoma: a study of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG IND.168)
Jennifer J. Knox, Sharlene Gill, Timothy W. Synold, James J. Biagi, Pierre Major, Ron Feld, Christine Cripps, Nancy Wainman, Elizabeth Eisenhauer, Lesley SeymourТом:
26
Мова:
english
Сторінки:
8
DOI:
10.1007/s10637-007-9103-2
Date:
June, 2008
Файл:
PDF, 338 KB
english, 2008
File converter
Більше результатів пошуку
More benefits 
